Opinion statement Soft tissue sarcomas (STS) are a rare and heterogeneous group of
malignancies that most commonly present as large painless masses deep in the muscular …

Earlier diagnosis is a key aim in achieving improved outcomes for patients with cancer.
Bone and soft tissue sarcomas represent approximately 1% of all malignant tumours. Delays …

Background The diagnosis of soft-tissue sarcomas of the limbs is often delayed, sometimes
markedly so, even though prompt and appropriate treatment improves survival and lowers …

Soft tissue sarcomas represent a heterogeneous group of rare malignancies exhibiting
mesenchymal differentiation with an overall incidence of around 5/100,000/year. Rarity and …

BACKGROUND: We assessed the occurrence of long-bone fracture and other side effects in
a group of 214 consecutive patients who underwent radical excision for soft-tissue sarcoma …

PURPOSE: To analyze the management and clinical outcome of patients treated for a first
isolated local recurrence of soft tissue sarcomas (trunk or extremities) and to identify …

Multidisciplinary care is essential for optimal clinical outcomes for soft tissue sarcoma (STS);
the care team should include providers with sarcoma expertise from surgical and orthopedic …

Purpose This guideline provides evidence-based recommendations addressing the
indications for radiation therapy (RT), sequencing of local therapies, and appropriate dose …

Soft-tissue sarcomas are a diverse group of rare mesenchymal malignancies that can arise
at any location in the body and affect all age groups. These sarcomas are most common in …

Radiotherapy and limb-preserving surgery has replaced amputation and compartmental
resection for treatment of soft tissue sarcomas. However, the role of radiotherapy in low …